|
FKBP15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.409000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.966400E-01 |
| Normal-vs-Stage2 |
8.730800E-01 |
| Normal-vs-Stage3 |
1.460850E-01 |
| Normal-vs-Stage4 |
4.015900E-02 |
| Stage1-vs-Stage2 |
8.417200E-01 |
| Stage1-vs-Stage3 |
5.036300E-02 |
| Stage1-vs-Stage4 |
1.902490E-02 |
| Stage2-vs-Stage3 |
1.459830E-01 |
| Stage2-vs-Stage4 |
6.016000E-02 |
| Stage3-vs-Stage4 |
4.212400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.485200E-01 |
| Normal-vs-AfricanAmerican |
8.920600E-01 |
| Normal-vs-Asian |
4.914600E-01 |
| Caucasian-vs-AfricanAmerican |
6.936200E-01 |
| Caucasian-vs-Asian |
1.463220E-01 |
| AfricanAmerican-vs-Asian |
5.006800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.832800E-01 |
| Normal-vs-Female |
3.984600E-01 |
| Male-vs-Female |
2.373400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.136800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.430600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.672800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.169600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.436010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.324410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.494600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.600600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.830800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.709600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.347600E-02 |
| Classical-VS-Follicular |
7.773400E-01 |
| Classical-VS-Other |
3.680800E-01 |
| Classical-VS-Normal |
8.538600E-01 |
| Tall-VS-Follicular |
1.114840E-01 |
| Tall-VS-Other |
7.960800E-01 |
| Tall-VS-Normal |
3.201700E-02 |
| Follicular-VS-Other |
5.221600E-01 |
| Follicular-VS-Normal |
7.055400E-01 |
| Other-VS-Normal |
2.975800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.465200E-01 |
| Normal-vs-N1 |
3.265700E-02 |
| N0-vs-N1 |
1.135510E-02 |
|
|
